{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:05:33Z","timestamp":1789445133114,"version":"build-2803163510"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32571192"],"award-info":[{"award-number":["32571192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["WK9100250104"],"award-info":[{"award-number":["WK9100250104"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"crossref","award":["0101099201"],"award-info":[{"award-number":["0101099201"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Higher Education Institutions of Anhui Province","award":["2025AHGXZK10011"],"award-info":[{"award-number":["2025AHGXZK10011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is one of the most aggressive and lethal primary brain tumors in adults, characterized by dynamic clonal evolution and extensive genomic, cellular, spatial, and microenvironmental heterogeneity. Multi-omics studies have revealed that GBM follows complex evolutionary trajectories involving genetic, epigenetic, transcriptional, and immune-microenvironmental remodeling as tumors grow, adapt to the brain microenvironment, and acquire therapeutic resistance. Increasing evidence suggests that GBM may originate from aberrant neural stem or progenitor cells, including those residing in the subventricular zone, and that glioblastoma stem cells (GSCs) contribute to tumor propagation, heterogeneity, and recurrence. A key conceptual challenge is to reconcile hierarchical cancer stem cell models, in which GSCs are viewed as relatively stable tumor-propagating subpopulations, with dynamic state plasticity models, in which stem-like properties can be reversibly acquired or lost during transitions among proneural-like, mesenchymal-like, invasive, and therapy-tolerant states. Recent advances in single-cell profiling, spatial transcriptomics, lineage tracing, organoid culture, 3D bioprinting, genetically engineered models, and artificial intelligence (AI)-assisted computational modeling have substantially improved the ability to study these processes. However, no currently available model fully recapitulates human GBM heterogeneity, recurrence, treatment history, and tumor\u2013microenvironment interactions. Therefore, model selection should be guided by clearly defined mechanistic questions rather than by reliance on any single platform. This review summarizes current advances in in vitro, ex vivo, in vivo, and computational models for studying GBM evolution and heterogeneity, and discusses how integrated model pipelines may improve preclinical drug testing, treatment-response prediction, and precision neuro-oncology.<\/jats:p>","DOI":"10.1186\/s13046-026-03767-7","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:16:07Z","timestamp":1782717367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding glioblastoma evolution and heterogeneity through mechanistic modeling: implications for clinical translation"],"prefix":"10.1186","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2477-5970","authenticated-orcid":false,"given":"Haowu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4054-1365","authenticated-orcid":false,"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"3767_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"3767_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459\u201366.","journal-title":"Lancet Oncol"},{"key":"3767_CR3","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1073\/pnas.1219747110","volume":"110","author":"A Sottoriva","year":"2013","unstructured":"Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, Marioni JC, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A. 2013;110:4009\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3767_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2017;32:42\u2013e566.","journal-title":"Cancer Cell"},{"key":"3767_CR5","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396\u2013401.","journal-title":"Science"},{"key":"3767_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.celrep.2017.10.030","volume":"21","author":"S Darmanis","year":"2017","unstructured":"Darmanis S, Sloan SA, Croote D, Mignardi M, Chernikova S, Samghababi P, et al. Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma. Cell Rep. 2017;21:1399\u2013410.","journal-title":"Cell Rep"},{"key":"3767_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12885-019-5861-4","volume":"19","author":"E Skaga","year":"2019","unstructured":"Skaga E, Kulesskiy E, Fayzullin A, Sandberg CJ, Potdar S, Kytt\u00e4l\u00e4 A, et al. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-na\u00efve glioblastoma. BMC Cancer. 2019;19:628.","journal-title":"BMC Cancer"},{"key":"3767_CR8","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang L, Jung J, Babikir H, Shamardani K, Jain S, Feng X, et al. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat Cancer. 2022;3:1534\u201352.","journal-title":"Nat Cancer"},{"key":"3767_CR9","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821\u20138.","journal-title":"Cancer Res"},{"key":"3767_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396\u2013401.","journal-title":"Nature"},{"key":"3767_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/brain\/awr081","volume":"134","author":"LP Deleyrolle","year":"2011","unstructured":"Deleyrolle LP, Harding A, Cato K, Siebzehnrubl FA, Rahman M, Azari H, et al. Evidence for label-retaining tumour-initiating cells in human glioblastoma. Brain. 2011;134:1331\u201343.","journal-title":"Brain"},{"key":"3767_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00441-010-1123-0","volume":"343","author":"G Tabatabai","year":"2011","unstructured":"Tabatabai G, Weller M. Glioblastoma stem cells. Cell Tissue Res. 2011;343:459\u201365.","journal-title":"Cell Tissue Res"},{"key":"3767_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1227\/01.neu.0000316019.28421.95","volume":"62","author":"AT Ogden","year":"2008","unstructured":"Ogden AT, Waziri AE, Lochhead RA, Fusco D, Lopez K, Ellis JA, et al. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery. 2008;62:505\u201314.","journal-title":"Neurosurgery"},{"key":"3767_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejca.2013.09.004","volume":"50","author":"SA Choi","year":"2014","unstructured":"Choi SA, Lee JY, Phi JH, Wang KC, Park CK, Park SH, et al. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase. Eur J Cancer. 2014;50:137\u201349.","journal-title":"Eur J Cancer"},{"key":"3767_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1101\/gad.324301.119","volume":"33","author":"RC Gimple","year":"2019","unstructured":"Gimple RC, Bhargava S, Dixit D, Rich JN. Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer. Genes Dev. 2019;33:591\u2013609.","journal-title":"Genes Dev"},{"key":"3767_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature23666","volume":"549","author":"X Lan","year":"2017","unstructured":"Lan X, J\u00f6rg DJ, Cavalli FMG, Richards LM, Nguyen LV, Vanner RJ, et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy. Nature. 2017;549:227\u201332.","journal-title":"Nature"},{"key":"3767_CR17","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","volume":"10","author":"A Dirkse","year":"2019","unstructured":"Dirkse A, Golebiewska A, Buder T, Nazarov PV, Muller A, Poovathingal S, et al. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nat Commun. 2019;10:1787.","journal-title":"Nat Commun"},{"key":"3767_CR18","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1038\/s41467-020-17186-5","volume":"11","author":"CP Couturier","year":"2020","unstructured":"Couturier CP, Ayyadhury S, Le PU, Nadaf J, Monlong J, Riva G, et al. Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. Nat Commun. 2020;11:3406.","journal-title":"Nat Commun"},{"key":"3767_CR19","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/cr.2011.83","volume":"21","author":"C Wang","year":"2011","unstructured":"Wang C, Liu F, Liu YY, Zhao CH, You Y, Wang L, et al. Identification and characterization of neuroblasts in the subventricular zone and rostral migratory stream of the adult human brain. Cell Res. 2011;21:1534\u201350.","journal-title":"Cell Res"},{"key":"3767_CR20","doi-asserted-by":"publisher","first-page":"a018812","DOI":"10.1101\/cshperspect.a018812","volume":"7","author":"G Kempermann","year":"2015","unstructured":"Kempermann G, Song H, Gage FH. Neurogenesis in the adult hippocampus. Cold Spring Harb Perspect Biol. 2015;7:a018812.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3767_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMra043666","volume":"353","author":"N Sanai","year":"2005","unstructured":"Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med. 2005;353:811\u201322.","journal-title":"N Engl J Med"},{"key":"3767_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-025-02167-5","volume":"57","author":"M Nomura","year":"2025","unstructured":"Nomura M, Spitzer A, Johnson KC, Garofano L, Nehar-Belaid D, Galili Darnell N, et al. The multilayered transcriptional architecture of glioblastoma ecosystems. Nat Genet. 2025;57:1155\u201367.","journal-title":"Nat Genet"},{"key":"3767_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178:835\u2013e4921.","journal-title":"Cell"},{"key":"3767_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/noab269","volume":"24","author":"YA Yabo","year":"2022","unstructured":"Yabo YA, Niclou SP, Golebiewska A. Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neuro Oncol. 2022;24:669\u201382.","journal-title":"Neuro Oncol"},{"key":"3767_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","volume":"22","author":"RC Gimple","year":"2022","unstructured":"Gimple RC, Yang K, Halbert ME, Agnihotri S, Rich JN. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat Rev Cancer. 2022;22:497\u2013514.","journal-title":"Nat Rev Cancer"},{"key":"3767_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","volume":"42","author":"KH Kim","year":"2024","unstructured":"Kim KH, Migliozzi S, Koo H, Hong JH, Park SM, Kim S, et al. Integrated proteogenomic characterization of glioblastoma evolution. Cancer Cell. 2024;42:358\u2013e3778.","journal-title":"Cancer Cell"},{"key":"3767_CR27","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3390\/ijms20112746","volume":"20","author":"M Fedele","year":"2019","unstructured":"Fedele M, Cerchia L, Pegoraro S, Sgarra R, Manfioletti G. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma. Int J Mol Sci. 2019;20:2746.","journal-title":"Int J Mol Sci"},{"key":"3767_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"KPL Bhat","year":"2013","unstructured":"Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, et al. Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma. Cancer Cell. 2013;24:331\u201346.","journal-title":"Cancer Cell"},{"key":"3767_CR29","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1016\/j.devcel.2024.09.003","volume":"59","author":"AEP Loftus","year":"2024","unstructured":"Loftus AEP, Romano MS, Phuong AN, McKinnel BJ, Muir MT, Furqan M, et al. An ILK\/STAT3 pathway controls glioblastoma stem cell plasticity. Dev Cell. 2024;59:3197\u2013e2127.","journal-title":"Dev Cell"},{"key":"3767_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.stem.2016.11.003","volume":"20","author":"BB Liau","year":"2017","unstructured":"Liau BB, Sievers C, Donohue LK, Gillespie SM, Flavahan WA, Miller TE, et al. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. Cell Stem Cell. 2017;20:233\u2013e2467.","journal-title":"Cell Stem Cell"},{"key":"3767_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/neuonc\/noad208","volume":"26","author":"M Cosenza-Contreras","year":"2024","unstructured":"Cosenza-Contreras M, Sch\u00e4fer A, Sing J, Cook L, Stillger MN, Chen CY, et al. Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism. Neuro Oncol. 2024;26:488\u2013502.","journal-title":"Neuro Oncol"},{"key":"3767_CR32","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.ccell.2024.06.004","volume":"42","author":"J Liu","year":"2024","unstructured":"Liu J, Cao S, Imbach KJ, Gritsenko MA, Lih TM, Kyle JE, et al. Multi-scale signaling and tumor evolution in high-grade gliomas. Cancer Cell. 2024;42:1217\u2013e3819.","journal-title":"Cancer Cell"},{"key":"3767_CR33","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, et al. Natural coevolution of tumor and immunoenvironment in Glioblastoma. Cancer Discov. 2022;12:2820\u201337.","journal-title":"Cancer Discov"},{"key":"3767_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2023.11.032","volume":"187","author":"D Kirschenbaum","year":"2024","unstructured":"Kirschenbaum D, Xie K, Ingelfinger F, Katzenelenbogen Y, Abadie K, Look T, et al. Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma. Cell. 2024;187:149\u2013e6523.","journal-title":"Cell"},{"key":"3767_CR35","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel E, Kapolou K, Unger S, N\u00fa\u00f1ez NG, Utz S, Rushing EJ, et al. Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes. Cell. 2020;181:1626\u2013e4220.","journal-title":"Cell"},{"key":"3767_CR36","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm F, Maas RR, Bowman RL, Kornete M, Soukup K, Nassiri S, et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell. 2020;181:1643\u2013e6017.","journal-title":"Cell"},{"key":"3767_CR37","doi-asserted-by":"publisher","first-page":"eade3559","DOI":"10.1126\/sciadv.ade3559","volume":"9","author":"R Sun","year":"2023","unstructured":"Sun R, Han R, McCornack C, Khan S, Tabor GT, Chen Y, et al. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma. Sci Adv. 2023;9:eade3559.","journal-title":"Sci Adv"},{"key":"3767_CR38","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41590-022-01215-0","volume":"23","author":"AT Yeo","year":"2022","unstructured":"Yeo AT, Rawal S, Delcuze B, Christofides A, Atayde A, Strauss L, et al. Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression. Nat Immunol. 2022;23:971\u201384.","journal-title":"Nat Immunol"},{"key":"3767_CR39","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","volume":"56","author":"A Sattiraju","year":"2023","unstructured":"Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity. 2023;56:1825\u201343. e6.","journal-title":"Immunity"},{"key":"3767_CR40","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41588-021-00927-7","volume":"53","author":"R Chaligne","year":"2021","unstructured":"Chaligne R, Gaiti F, Silverbush D, Schiffman JS, Weisman HR, Kluegel L, et al. Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states. Nat Genet. 2021;53:1469\u201379.","journal-title":"Nat Genet"},{"key":"3767_CR41","doi-asserted-by":"publisher","first-page":"e163446","DOI":"10.1172\/JCI163446","volume":"133","author":"F Khan","year":"2023","unstructured":"Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest. 2023;133:e163446.","journal-title":"J Clin Invest"},{"key":"3767_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes AR, Scheyltjens I, Lodi F, Messiaen J, Antoranz A, Duerinck J, et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci. 2021;24:595\u2013610.","journal-title":"Nat Neurosci"},{"key":"3767_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.3590","volume":"48","author":"J Wang","year":"2016","unstructured":"Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S, et al. Clonal evolution of glioblastoma under therapy. Nat Genet. 2016;48:768\u201376.","journal-title":"Nat Genet"},{"key":"3767_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/neuonc\/noae214","volume":"27","author":"CG Lucas","year":"2025","unstructured":"Lucas CG, Al-Adli NN, Young JS, Gupta R, Morshed RA, Wu J, et al. Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025;27:89\u2013105.","journal-title":"Neuro Oncol"},{"key":"3767_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.semcancer.2020.12.003","volume":"82","author":"T Kondo","year":"2022","unstructured":"Kondo T. Glioblastoma-initiating cell heterogeneity generated by the cell-of-origin, genetic\/epigenetic mutation and microenvironment. Semin Cancer Biol. 2022;82:176\u201383.","journal-title":"Semin Cancer Biol"},{"key":"3767_CR46","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.cell.2021.03.023","volume":"184","author":"E Gangoso","year":"2021","unstructured":"Gangoso E, Southgate B, Bradley L, Rus S, Galvez-Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454\u201370. e26.","journal-title":"Cell"},{"key":"3767_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s43018-023-00709-6","volume":"5","author":"SJ Bagley","year":"2024","unstructured":"Bagley SJ, Binder ZA, Lamrani L, Marinari E, Desai AS, Nasrallah MP, et al. Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nat Cancer. 2024;5:517\u201331.","journal-title":"Nat Cancer"},{"key":"3767_CR48","doi-asserted-by":"publisher","first-page":"10757","DOI":"10.1038\/s41467-024-54326-7","volume":"15","author":"JR McFaline-Figueroa","year":"2024","unstructured":"McFaline-Figueroa JR, Sun L, Youssef GC, Huang R, Li G, Kim J, et al. Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort. Nat Commun. 2024;15:10757.","journal-title":"Nat Commun"},{"key":"3767_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccell.2022.02.016","volume":"40","author":"VG LeBlanc","year":"2022","unstructured":"LeBlanc VG, Trinh DL, Aslanpour S, Hughes M, Livingstone D, Jin D, et al. Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity. Cancer Cell. 2022;40:379\u2013e929.","journal-title":"Cancer Cell"},{"key":"3767_CR50","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-025-02168-4","volume":"57","author":"A Spitzer","year":"2025","unstructured":"Spitzer A, Johnson KC, Nomura M, Garofano L, Nehar-Belaid D, Darnell NG, et al. Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. Nat Genet. 2025;57:1168\u201378.","journal-title":"Nat Genet"},{"key":"3767_CR51","doi-asserted-by":"publisher","first-page":"114067","DOI":"10.1016\/j.addr.2021.114067","volume":"180","author":"TJ DePalma","year":"2022","unstructured":"DePalma TJ, Sivakumar H, Skardal A. Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma. Adv Drug Deliv Rev. 2022;180:114067.","journal-title":"Adv Drug Deliv Rev"},{"key":"3767_CR52","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-018-0070-7","volume":"15","author":"S Bian","year":"2018","unstructured":"Bian S, Repic M, Guo Z, Kavirayani A, Burkard T, Bagley JA, et al. Genetically engineered cerebral organoids model brain tumor formation. Nat Methods. 2018;15:631\u20139.","journal-title":"Nat Methods"},{"key":"3767_CR53","doi-asserted-by":"publisher","first-page":"eabi9119","DOI":"10.1126\/sciadv.abi9119","volume":"7","author":"L Neufeld","year":"2021","unstructured":"Neufeld L, Yeini E, Reisman N, Shtilerman Y, Ben-Shushan D, Pozzi S, et al. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Sci Adv. 2021;7:eabi9119.","journal-title":"Sci Adv"},{"key":"3767_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0378-1119(00)00297-3","volume":"255","author":"TA Kim","year":"2000","unstructured":"Kim TA, Ota S, Jiang S, Pasztor LM, White RA, Avraham S. Genomic organization, chromosomal localization and regulation of expression of the neuronal nuclear matrix protein NRP\/B in human brain tumors. Gene. 2000;255:105\u201316.","journal-title":"Gene"},{"key":"3767_CR55","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/cancers13081780","volume":"13","author":"P Shaw","year":"2021","unstructured":"Shaw P, Kumar N, Privat-Maldonado A, Smits E, Bogaerts A. Cold atmospheric plasma increases temozolomide sensitivity of three-dimensional glioblastoma spheroids via oxidative stress-mediated DNA damage. Cancers (Basel). 2021;13:1780.","journal-title":"Cancers (Basel)"},{"key":"3767_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-009-9875-7","volume":"94","author":"RF Barth","year":"2009","unstructured":"Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol. 2009;94:299\u2013312.","journal-title":"J Neurooncol"},{"key":"3767_CR57","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/jcb.22478","volume":"109","author":"AS Tamajusuku","year":"2010","unstructured":"Tamajusuku AS, Villodre ES, Paulus R, Coutinho-Silva R, Battasstini AM, Wink MR, et al. Characterization of ATP-induced cell death in the GL261 mouse glioma. J Cell Biochem. 2010;109:983\u201391.","journal-title":"J Cell Biochem"},{"key":"3767_CR58","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1002\/jcb.23228","volume":"112","author":"F Li","year":"2011","unstructured":"Li F, Cheng Y, Lu J, Hu R, Wan Q, Feng H. Photodynamic therapy boosts anti-glioma immunity in mice: a dependence on the activities of T cells and complement C3. J Cell Biochem. 2011;112:3035\u201343.","journal-title":"J Cell Biochem"},{"key":"3767_CR59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00005072-198105000-00001","volume":"40","author":"DD Bigner","year":"1981","unstructured":"Bigner DD, Bigner SH, Pont\u00e9n J, Westermark B, Mahaley MS, Ruoslahti E, et al. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol. 1981;40:201\u201329.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3767_CR60","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0959-8049(92)90471-D","volume":"28A","author":"C Chauzy","year":"1992","unstructured":"Chauzy C, Delpech B, Olivier A, Bastard C, Girard N, Courel MN, et al. Establishment and characterisation of a human glioma cell line. Eur J Cancer. 1992;28A:1129\u201334.","journal-title":"Eur J Cancer"},{"key":"3767_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF03159989","volume":"17","author":"TN Seyfried","year":"1992","unstructured":"Seyfried TN, el-Abbadi M, Roy ML. Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol. 1992;17:147\u201367.","journal-title":"Mol Chem Neuropathol"},{"key":"3767_CR62","doi-asserted-by":"publisher","first-page":"e1501137","DOI":"10.1080\/2162402X.2018.1501137","volume":"7","author":"V Genoud","year":"2018","unstructured":"Genoud V, Marinari E, Nikolaev SI, Castle JC, Bukur V, Dietrich PY, et al. Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models. Oncoimmunology. 2018;7:e1501137.","journal-title":"Oncoimmunology"},{"key":"3767_CR63","doi-asserted-by":"publisher","first-page":"e002181","DOI":"10.1136\/jitc-2020-002181","volume":"9","author":"EF Simonds","year":"2021","unstructured":"Simonds EF, Lu ED, Badillo O, Karimi S, Liu EV, Tamaki W, et al. Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. J Immunother Cancer. 2021;9:e002181.","journal-title":"J Immunother Cancer"},{"key":"3767_CR64","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2021.11.FOCUS21556","volume":"52","author":"V Letchuman","year":"2022","unstructured":"Letchuman V, Ampie L, Shah AH, Brown DA, Heiss JD, Chittiboina P. Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes. Neurosurg Focus. 2022;52:E5.","journal-title":"Neurosurg Focus"},{"key":"3767_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-385928-0.00002-X","volume":"491","author":"TC Chen","year":"2011","unstructured":"Chen TC. GRP78\/BiP modulation of GRP78\/BiP in altering sensitivity to chemotherapy. Methods Enzymol. 2011;491:25\u201336.","journal-title":"Methods Enzymol"},{"key":"3767_CR66","first-page":"1351","volume":"2","author":"Y Xie","year":"2015","unstructured":"Xie Y, Bergstr\u00f6m T, Jiang Y, Johansson P, Marinescu VD, Lindberg N, et al. Hum Glioblastoma Cell Cult Resource: Validated Cell Models Representing All Mol Subtypes EBioMedicine. 2015;2:1351\u201363.","journal-title":"Hum Glioblastoma Cell Cult Resource: Validated Cell Models Representing All Mol Subtypes EBioMedicine"},{"key":"3767_CR67","doi-asserted-by":"publisher","first-page":"43452","DOI":"10.18632\/oncotarget.6171","volume":"6","author":"V Patil","year":"2015","unstructured":"Patil V, Pal J, Somasundaram K. Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing. Oncotarget. 2015;6:43452\u201371.","journal-title":"Oncotarget"},{"key":"3767_CR68","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/biomedicines12010238","volume":"12","author":"E Begagi\u0107","year":"2024","unstructured":"Begagi\u0107 E, Be\u010duli\u0107 H, \u0110uzi\u0107 N, D\u017eidi\u0107-Krivi\u0107 A, Pugonja R, Muharemovi\u0107 A, et al. CRISPR\/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. Biomedicines. 2024;12:238.","journal-title":"Biomedicines"},{"key":"3767_CR69","doi-asserted-by":"publisher","first-page":"189059","DOI":"10.1016\/j.bbcan.2023.189059","volume":"1879","author":"V Pasupuleti","year":"2024","unstructured":"Pasupuleti V, Vora L, Prasad R, Nandakumar DN, Khatri DK. Glioblastoma preclinical models: Strengths and weaknesses. Biochim Biophys Acta Rev Cancer. 2024;1879:189059.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3767_CR70","doi-asserted-by":"publisher","first-page":"354re3","DOI":"10.1126\/scitranslmed.aaf6853","volume":"8","author":"M Allen","year":"2016","unstructured":"Allen M, Bjerke M, Edlund H, Nelander S, Westermark B. Origin of the U87MG glioma cell line: Good news and bad news. Sci Transl Med. 2016;8:354re3.","journal-title":"Sci Transl Med"},{"key":"3767_CR71","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-04-1364","volume":"64","author":"R Galli","year":"2004","unstructured":"Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64:7011\u201321.","journal-title":"Cancer Res"},{"key":"3767_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105\u201311.","journal-title":"Nature"},{"key":"3767_CR73","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756\u201360.","journal-title":"Nature"},{"key":"3767_CR74","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488:522\u20136.","journal-title":"Nature"},{"key":"3767_CR75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11060-023-04287-6","volume":"163","author":"E Lazzarini","year":"2023","unstructured":"Lazzarini E, Silvestris DA, Benvenuto G, Osti D, Fattore L, Paterra R, et al. Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors. J Neurooncol. 2023;163:47\u201359.","journal-title":"J Neurooncol"},{"key":"3767_CR76","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ccell.2020.04.001","volume":"37","author":"ML Suv\u00e0","year":"2020","unstructured":"Suv\u00e0 ML, Tirosh I. The glioma stem cell model in the era of single-cell genomics. Cancer Cell. 2020;37:630\u20136.","journal-title":"Cancer Cell"},{"key":"3767_CR77","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2174\/1381612826666200131100630","volume":"26","author":"SH Shahcheraghi","year":"2020","unstructured":"Shahcheraghi SH, Tchokonte-Nana V, Lotfi M, Lotfi M, Ghorbani A, Sadeghnia HR. Wnt\/beta-catenin and PI3K\/Akt\/mTOR signaling pathways in glioblastoma: two main targets for drug design: A Review. Curr Pharm Des. 2020;26:1729\u201341.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"3767_CR78","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1172\/JCI128994","volume":"130","author":"A El-Sehemy","year":"2020","unstructured":"El-Sehemy A, Selvadurai H, Ortin-Martinez A, Pokrajac N, Mamatjan Y, Tachibana N, et al. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt. J Clin Invest. 2020;130(6):3069\u201386.","journal-title":"J Clin Invest"},{"key":"3767_CR79","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2008.323","volume":"19","author":"T Watabe","year":"2009","unstructured":"Watabe T, Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res. 2009;19:103\u201315.","journal-title":"Cell Res"},{"key":"3767_CR80","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560:325\u201330.","journal-title":"Nature"},{"key":"3767_CR81","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1476-4598-3-25","volume":"3","author":"P Tunici","year":"2004","unstructured":"Tunici P, Bissola L, Lualdi E, Pollo B, Cajola L, Broggi G, et al. Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Mol Cancer. 2004;3:25.","journal-title":"Mol Cancer"},{"key":"3767_CR82","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","volume":"4","author":"SM Pollard","year":"2009","unstructured":"Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 2009;4:568\u201380.","journal-title":"Cell Stem Cell"},{"key":"3767_CR83","doi-asserted-by":"publisher","first-page":"102705","DOI":"10.1016\/j.xpro.2023.102705","volume":"4","author":"F De Bacco","year":"2023","unstructured":"De Bacco F, Orzan F, Casanova E, Prelli M, Boccaccio C. Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumors. STAR Protoc. 2023;4:102705.","journal-title":"STAR Protoc"},{"key":"3767_CR84","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2353\/ajpath.2010.091021","volume":"177","author":"EE Bar","year":"2010","unstructured":"Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol. 2010;177:1491\u2013502.","journal-title":"Am J Pathol"},{"key":"3767_CR85","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0140-6736(05)66879-1","volume":"366","author":"A Vats","year":"2005","unstructured":"Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM. Stem cells. Lancet. 2005;366:592\u2013602.","journal-title":"Lancet"},{"key":"3767_CR86","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pa\u015fca","year":"2015","unstructured":"Pa\u015fca AM, Sloan SA, Clarke LE, Tian Y, Makinson CD, Huber N, et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods. 2015;12:671\u20138.","journal-title":"Nat Methods"},{"key":"3767_CR87","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.10.015","volume":"19","author":"Y Tao","year":"2016","unstructured":"Tao Y, Zhang SC. Neural subtype specification from human pluripotent stem cells. Cell Stem Cell. 2016;19:573\u201386.","journal-title":"Cell Stem Cell"},{"key":"3767_CR88","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/neuonc\/noad034","volume":"25","author":"C Schloo","year":"2023","unstructured":"Schloo C, Kutscher LM. Modeling brain and neural crest neoplasms with human pluripotent stem cells. Neuro Oncol. 2023;25:1225\u201335.","journal-title":"Neuro Oncol"},{"key":"3767_CR89","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"IH Park","year":"2008","unstructured":"Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141\u20136.","journal-title":"Nature"},{"key":"3767_CR90","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917\u201320.","journal-title":"Science"},{"key":"3767_CR91","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1242\/dev.140855","volume":"144","author":"RB Bressan","year":"2017","unstructured":"Bressan RB, Dewari PS, Kalantzaki M, Gangoso E, Matjusaitis M, Garcia-Diaz C, et al. Efficient CRISPR\/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells. Development. 2017;144:635\u201348.","journal-title":"Development"},{"key":"3767_CR92","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41467-020-14312-1","volume":"11","author":"T Koga","year":"2020","unstructured":"Koga T, Chaim IA, Benitez JA, Markmiller S, Parisian AD, Hevner RF, et al. Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells. Nat Commun. 2020;11:550.","journal-title":"Nat Commun"},{"key":"3767_CR93","doi-asserted-by":"publisher","first-page":"10068","DOI":"10.1038\/ncomms10068","volume":"6","author":"S Duan","year":"2015","unstructured":"Duan S, Yuan G, Liu X, Ren R, Li J, Zhang W, et al. PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype. Nat Commun. 2015;6:10068.","journal-title":"Nat Commun"},{"key":"3767_CR94","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1535-6108(02)00046-6","volume":"1","author":"RM Bachoo","year":"2002","unstructured":"Bachoo RM, Maher EA, Ligon KL, Sharpless NE, Chan SS, You MJ, et al. Epidermal growth factor receptor and Ink4a\/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell. 2002;1:269\u201377.","journal-title":"Cancer Cell"},{"key":"3767_CR95","doi-asserted-by":"publisher","first-page":"10743","DOI":"10.1038\/ncomms10743","volume":"7","author":"I Sancho-Martinez","year":"2016","unstructured":"Sancho-Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743.","journal-title":"Nat Commun"},{"key":"3767_CR96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/neuonc\/nox036.091","volume":"19","author":"N Gomez-Roman","year":"2017","unstructured":"Gomez-Roman N, Stevenson K, Gilmour L, Hamilton G, Chalmers AJ. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses. Neuro Oncol. 2017;19:229\u201341.","journal-title":"Neuro Oncol"},{"key":"3767_CR97","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3390\/pharmaceutics14102243","volume":"14","author":"JL King","year":"2022","unstructured":"King JL, Maturavongsadit P, Hingtgen SD, Benhabbour SR. Injectable pH thermo-responsive hydrogel scaffold for tumoricidal neural stem cell therapy for glioblastoma multiforme. Pharmaceutics. 2022;14:2243.","journal-title":"Pharmaceutics"},{"key":"3767_CR98","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","volume":"31","author":"WH Abuwatfa","year":"2024","unstructured":"Abuwatfa WH, Pitt WG, Husseini GA. Scaffold-based 3D cell culture models in cancer research. J Biomed Sci. 2024;31:7.","journal-title":"J Biomed Sci"},{"key":"3767_CR99","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biomaterials.2016.10.052","volume":"115","author":"S Pradhan","year":"2017","unstructured":"Pradhan S, Clary JM, Seliktar D, Lipke EA. A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres. Biomaterials. 2017;115:141\u201354.","journal-title":"Biomaterials"},{"key":"3767_CR100","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/jbm.a.37093","volume":"109","author":"D Zhu","year":"2021","unstructured":"Zhu D, Trinh P, Li J, Grant GA, Yang F. Gradient hydrogels for screening stiffness effects on patient-derived glioblastoma xenograft cell fates in 3D. J Biomed Mater Res A. 2021;109:1027\u201335.","journal-title":"J Biomed Mater Res A"},{"key":"3767_CR101","doi-asserted-by":"publisher","first-page":"e2201888","DOI":"10.1002\/advs.202201888","volume":"9","author":"MT Ngo","year":"2022","unstructured":"Ngo MT, Sarkaria JN, Harley BAC. Perivascular stromal cells instruct glioblastoma invasion, proliferation, and therapeutic response within an engineered brain perivascular niche model. Adv Sci (Weinh). 2022;9:e2201888.","journal-title":"Adv Sci (Weinh)"},{"key":"3767_CR102","doi-asserted-by":"publisher","first-page":"14982","DOI":"10.1038\/s41598-022-19175-8","volume":"12","author":"TJ Grundy","year":"2022","unstructured":"Grundy TJ, Orcheston-Findlay L, de Silva E, Jegathees T, Prior V, Sarker FA, et al. Mechanosensitive expression of the mesenchymal subtype marker connective tissue growth factor in glioblastoma. Sci Rep. 2022;12:14982.","journal-title":"Sci Rep"},{"key":"3767_CR103","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","volume":"19","author":"G Rossi","year":"2018","unstructured":"Rossi G, Manfrin A, Lutolf MP. Progress and potential in organoid research. Nat Rev Genet. 2018;19:671\u201387.","journal-title":"Nat Rev Genet"},{"key":"3767_CR104","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.stem.2019.05.007","volume":"24","author":"J Mariani","year":"2019","unstructured":"Mariani J, Vaccarino FM. Breakthrough Moments: Yoshiki Sasai\u2019s Discoveries in the Third Dimension. Cell Stem Cell. 2019;24:837\u20138.","journal-title":"Cell Stem Cell"},{"key":"3767_CR105","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","volume":"76","author":"CG Hubert","year":"2016","unstructured":"Hubert CG, Rivera M, Spangler LC, Wu Q, Mack SC, Prager BC, et al. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 2016;76:2465\u201377.","journal-title":"Cancer Res"},{"key":"3767_CR106","first-page":"vdad152","volume":"5","author":"M Verduin","year":"2023","unstructured":"Verduin M, Hoosemans L, Vanmechelen M, van Heumen M, Piepers JAF, Astuti G, et al. Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. Neurooncol Adv. 2023;5:vdad152.","journal-title":"Neurooncol Adv"},{"key":"3767_CR107","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501:373\u20139.","journal-title":"Nature"},{"key":"3767_CR108","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41593-020-00730-3","volume":"23","author":"I Chiaradia","year":"2020","unstructured":"Chiaradia I, Lancaster MA. Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo. Nat Neurosci. 2020;23:1496\u2013508.","journal-title":"Nat Neurosci"},{"key":"3767_CR109","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","volume":"3","author":"M Eiraku","year":"2008","unstructured":"Eiraku M, Watanabe K, Matsuo-Takasaki M, Kawada M, Yonemura S, Matsumura M, et al. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell. 2008;3:519\u201332.","journal-title":"Cell Stem Cell"},{"key":"3767_CR110","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc. 2014;9:2329\u201340.","journal-title":"Nat Protoc"},{"key":"3767_CR111","doi-asserted-by":"publisher","first-page":"20284","DOI":"10.1073\/pnas.1315710110","volume":"110","author":"T Kadoshima","year":"2013","unstructured":"Kadoshima T, Sakaguchi H, Nakano T, Soen M, Ando S, Eiraku M, et al. Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc Natl Acad Sci U S A. 2013;110:20284\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3767_CR112","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","volume":"23","author":"J Ogawa","year":"2018","unstructured":"Ogawa J, Pao GM, Shokhirev MN, Verma IM. Glioblastoma model using human cerebral organoids. Cell Rep. 2018;23:1220\u20139.","journal-title":"Cell Rep"},{"key":"3767_CR113","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","volume":"26","author":"A Linkous","year":"2019","unstructured":"Linkous A, Balamatsias D, Snuderl M, Edwards L, Miyaguchi K, Milner T, et al. Modeling patient-derived glioblastoma with cerebral organoids. Cell Rep. 2019;26:3203\u2013e115.","journal-title":"Cell Rep"},{"key":"3767_CR114","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/neuonc\/noaa091","volume":"22","author":"TG Krieger","year":"2020","unstructured":"Krieger TG, Tirier SM, Park J, Jechow K, Eisemann T, Peterziel H, et al. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics. Neuro Oncol. 2020;22:1138\u201349.","journal-title":"Neuro Oncol"},{"key":"3767_CR115","doi-asserted-by":"publisher","first-page":"107738","DOI":"10.1016\/j.celrep.2020.107738","volume":"31","author":"G Goranci-Buzhala","year":"2020","unstructured":"Goranci-Buzhala G, Mariappan A, Gabriel E, Ramani A, Ricci-Vitiani L, Buccarelli M, et al. Rapid and efficient invasion assay of glioblastoma in human brain organoids. Cell Rep. 2020;31:107738.","journal-title":"Cell Rep"},{"key":"3767_CR116","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1158\/2159-8290.CD-23-1336","volume":"15","author":"V Mangena","year":"2025","unstructured":"Mangena V, Chanoch-Myers R, Sartore R, Paulsen B, Gritsch S, Weisman H, et al. Glioblastoma cortical organoids recapitulate cell-state heterogeneity and intercellular transfer. Cancer Discov. 2025;15:299\u2013315.","journal-title":"Cancer Discov"},{"key":"3767_CR117","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/2472555218764623","volume":"23","author":"B da Silva","year":"2018","unstructured":"da Silva B, Mathew RK, Polson ES, Williams J, Wurdak H. Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion. SLAS Discov. 2018;23:862\u20138.","journal-title":"SLAS Discov"},{"key":"3767_CR118","doi-asserted-by":"publisher","first-page":"604121","DOI":"10.3389\/fonc.2020.604121","volume":"10","author":"E Klein","year":"2020","unstructured":"Klein E, Hau AC, Oudin A, Golebiewska A, Niclou SP. Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. Front Oncol. 2020;10:604121.","journal-title":"Front Oncol"},{"key":"3767_CR119","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3171\/jns.1990.72.3.0463","volume":"72","author":"R Bjerkvig","year":"1990","unstructured":"Bjerkvig R, T\u00f8nnesen A, Laerum OD, Backlund EO. Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg. 1990;72:463\u201375.","journal-title":"J Neurosurg"},{"key":"3767_CR120","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH, et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell. 2020;180:188\u2013e20422.","journal-title":"Cell"},{"key":"3767_CR121","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.stem.2024.11.010","volume":"32","author":"M Logun","year":"2025","unstructured":"Logun M, Wang X, Sun Y, Bagley SJ, Li N, Desai A, et al. Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. Cell Stem Cell. 2025;32:181\u2013e1904.","journal-title":"Cell Stem Cell"},{"key":"3767_CR122","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.stem.2025.01.002","volume":"32","author":"T Peng","year":"2025","unstructured":"Peng T, Ma X, Hua W, Wang C, Chu Y, Sun M, et al. Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy. Cell Stem Cell. 2025;32:652\u2013e6911.","journal-title":"Cell Stem Cell"},{"key":"3767_CR123","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1226340","volume":"338","author":"B Derby","year":"2012","unstructured":"Derby B. Printing and prototyping of tissues and scaffolds. Science. 2012;338:921\u20136.","journal-title":"Science"},{"key":"3767_CR124","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nbt.2958","volume":"32","author":"SV Murphy","year":"2014","unstructured":"Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32:773\u201385.","journal-title":"Nat Biotechnol"},{"key":"3767_CR125","doi-asserted-by":"publisher","unstructured":"Decante G, Costa JB, Silva-Correia J, Collins MN, Reis RL, Oliveira JM. Engineering bioinks for 3D bioprinting. Biofabrication. 2021;13. https:\/\/doi.org\/10.1088\/1758-5090\/abec2c.","DOI":"10.1088\/1758-5090\/abec2c"},{"key":"3767_CR126","doi-asserted-by":"publisher","first-page":"119536","DOI":"10.1016\/j.biomaterials.2019.119536","volume":"226","author":"I Matai","year":"2020","unstructured":"Matai I, Kaur G, Seyedsalehi A, McClinton A, Laurencin CT. Progress in 3D bioprinting technology for tissue\/organ regenerative engineering. Biomaterials. 2020;226:119536.","journal-title":"Biomaterials"},{"key":"3767_CR127","doi-asserted-by":"publisher","unstructured":"Gong J, Qian Y, Lu K, Zhu Z, Siow L, Zhang C, et al. Digital light processing (DLP) in tissue engineering: from promise to reality, and perspectives. Biomed Mater. 2022;17. https:\/\/doi.org\/10.1088\/1748-605X\/ac96ba.","DOI":"10.1088\/1748-605X\/ac96ba"},{"key":"3767_CR128","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.tibtech.2015.06.007","volume":"33","author":"S Knowlton","year":"2015","unstructured":"Knowlton S, Onal S, Yu CH, Zhao JJ, Tasoglu S. Bioprinting for cancer research. Trends Biotechnol. 2015;33:504\u201313.","journal-title":"Trends Biotechnol"},{"key":"3767_CR129","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1039\/D2BM02060B","volume":"11","author":"R Sharma","year":"2023","unstructured":"Sharma R, Restan Perez M, da Silva VA, Thomsen J, Bhardwaj L, Andrade TAM, et al. 3D bioprinting complex models of cancer. Biomater Sci. 2023;11:3414\u201330.","journal-title":"Biomater Sci"},{"key":"3767_CR130","doi-asserted-by":"publisher","first-page":"045005","DOI":"10.1088\/1758-5090\/8\/4\/045005","volume":"8","author":"X Dai","year":"2016","unstructured":"Dai X, Ma C, Lan Q, Xu T. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Biofabrication. 2016;8:045005.","journal-title":"Biofabrication"},{"key":"3767_CR131","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s12079-018-0469-z","volume":"12","author":"DM van Pel","year":"2018","unstructured":"van Pel DM, Harada K, Song D, Naus CC, Sin WC. Modelling glioma invasion using 3D bioprinting and scaffold-free 3D culture. J Cell Commun Signal. 2018;12:723\u201330.","journal-title":"J Cell Commun Signal"},{"key":"3767_CR132","doi-asserted-by":"publisher","first-page":"e1806590","DOI":"10.1002\/adma.201806590","volume":"31","author":"MA Heinrich","year":"2019","unstructured":"Heinrich MA, Bansal R, Lammers T, Zhang YS, Michel Schiffelers R, Prakash J. 3D-bioprinted mini-brain: a glioblastoma model to study cellular interactions and therapeutics. Adv Mater. 2019;31:e1806590.","journal-title":"Adv Mater"},{"key":"3767_CR133","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41422-020-0338-1","volume":"30","author":"M Tang","year":"2020","unstructured":"Tang M, Xie Q, Gimple RC, Zhong Z, Tam T, Tian J, et al. Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions. Cell Res. 2020;30:833\u201353.","journal-title":"Cell Res"},{"key":"3767_CR134","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb3090","volume":"17","author":"W Zhou","year":"2015","unstructured":"Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol. 2015;17:170\u201382.","journal-title":"Nat Cell Biol"},{"key":"3767_CR135","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1038\/s41467-018-04919-w","volume":"9","author":"F Eduati","year":"2018","unstructured":"Eduati F, Utharala R, Madhavan D, Neumann UP, Longerich T, Cramer T, et al. A microfluidics platform for combinatorial drug screening on cancer biopsies. Nat Commun. 2018;9:2434.","journal-title":"Nat Commun"},{"key":"3767_CR136","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1158\/0008-5472.CAN-12-2838","volume":"73","author":"JM Munson","year":"2013","unstructured":"Munson JM, Bellamkonda RV, Swartz MA. Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism. Cancer Res. 2013;73:1536\u201346.","journal-title":"Cancer Res"},{"key":"3767_CR137","doi-asserted-by":"publisher","first-page":"e2118697119","DOI":"10.1073\/pnas.2118697119","volume":"119","author":"JP Straehla","year":"2022","unstructured":"Straehla JP, Hajal C, Safford HC, Offeddu GS, Boehnke N, Dacoba TG, et al. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles. Proc Natl Acad Sci U S A. 2022;119:e2118697119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3767_CR138","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41596-021-00635-w","volume":"17","author":"C Hajal","year":"2022","unstructured":"Hajal C, Offeddu GS, Shin Y, Zhang S, Morozova O, Hickman D, et al. Engineered human blood-brain barrier microfluidic model for vascular permeability analyses. Nat Protoc. 2022;17:95\u2013128.","journal-title":"Nat Protoc"},{"key":"3767_CR139","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","volume":"20","author":"LA Low","year":"2021","unstructured":"Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. Organs-on-chips: into the next decade. Nat Rev Drug Discov. 2021;20:345\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"3767_CR140","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41551-019-0363-x","volume":"3","author":"HG Yi","year":"2019","unstructured":"Yi HG, Jeong YH, Kim Y, Choi YJ, Moon HE, Park SH, et al. A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nat Biomed Eng. 2019;3:509\u201319.","journal-title":"Nat Biomed Eng"},{"key":"3767_CR141","doi-asserted-by":"publisher","first-page":"e52253","DOI":"10.7554\/eLife.52253","volume":"9","author":"X Cui","year":"2020","unstructured":"Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, et al. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. Elife. 2020;9:e52253.","journal-title":"Elife"},{"key":"3767_CR142","doi-asserted-by":"publisher","first-page":"e2405511","DOI":"10.1002\/smll.202405511","volume":"21","author":"S Maity","year":"2025","unstructured":"Maity S, Bhuyan T, Jewell C, Kawakita S, Sharma S, Nguyen HT, et al. Recent Developments in Glioblastoma-On-A-Chip for Advanced Drug Screening Applications. Small. 2025;21:e2405511.","journal-title":"Small"},{"key":"3767_CR143","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neuroscience.2015.07.086","volume":"305","author":"C Humpel","year":"2015","unstructured":"Humpel C. Organotypic brain slice cultures: A review. Neuroscience. 2015;305:86\u201398.","journal-title":"Neuroscience"},{"key":"3767_CR144","first-page":"2935","volume":"58","author":"T Ohnishi","year":"1998","unstructured":"Ohnishi T, Matsumura H, Izumoto S, Hiraga S, Hayakawa T. A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res. 1998;58:2935\u201340.","journal-title":"Cancer Res"},{"key":"3767_CR145","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-023-04349-9","volume":"164","author":"R Ravin","year":"2023","unstructured":"Ravin R, Suarez-Meade P, Busse B, Blank PS, Vivas-Buitrago T, Norton ES, et al. Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain. J Neurooncol. 2023;164:43\u201354.","journal-title":"J Neurooncol"},{"key":"3767_CR146","doi-asserted-by":"publisher","first-page":"dmm031435","DOI":"10.1242\/dmm.031435","volume":"11","author":"MA Marques-Torrejon","year":"2018","unstructured":"Marques-Torrejon MA, Gangoso E, Pollard SM. Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture. Dis Model Mech. 2018;11:dmm031435.","journal-title":"Dis Model Mech"},{"key":"3767_CR147","doi-asserted-by":"publisher","first-page":"e201900305","DOI":"10.26508\/lsa.201900305","volume":"2","author":"VM Ravi","year":"2019","unstructured":"Ravi VM, Joseph K, Wurm J, Behringer S, Garrelfs N, d\u2019Errico P, et al. Human organotypic brain slice culture: a novel framework for environmental research in neuro-oncology. Life Sci Alliance. 2019;2:e201900305.","journal-title":"Life Sci Alliance"},{"key":"3767_CR148","first-page":"53557","volume":"125","author":"JJ Parker","year":"2017","unstructured":"Parker JJ, Lizarraga M, Waziri A, Foshay KM. A human glioblastoma organotypic slice culture model for study of tumor cell migration and patient-specific effects of anti-invasive drugs. J Vis Exp. 2017;125:53557.","journal-title":"J Vis Exp"},{"key":"3767_CR149","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12885-018-4007-4","volume":"18","author":"T Eisemann","year":"2018","unstructured":"Eisemann T, Costa B, Strelau J, Mittelbronn M, Angel P, Peterziel H. An advanced glioma cell invasion assay based on organotypic brain slice cultures. BMC Cancer. 2018;18:103.","journal-title":"BMC Cancer"},{"key":"3767_CR150","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1074\/jbc.M112.386722","volume":"288","author":"S Shimamura","year":"2013","unstructured":"Shimamura S, Sasaki K, Tanaka M. The Src substrate SKAP2 regulates actin assembly by interacting with WAVE2 and cortactin proteins. J Biol Chem. 2013;288:1171\u201383.","journal-title":"J Biol Chem"},{"key":"3767_CR151","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/neuonc\/noad101","volume":"25","author":"U Kuliesiute","year":"2023","unstructured":"Kuliesiute U, Joseph K, Straehle J, Madapusi Ravi V, Kueckelhaus J, Kada Benotmane J, et al. Sialic acid metabolism orchestrates transcellular connectivity and signaling in glioblastoma. Neuro Oncol. 2023;25:1963\u201375.","journal-title":"Neuro Oncol"},{"key":"3767_CR152","doi-asserted-by":"publisher","first-page":"969787","DOI":"10.3389\/fonc.2022.969787","volume":"12","author":"EL Ivanova","year":"2022","unstructured":"Ivanova EL, Costa B, Eisemann T, Lohr S, Boskovic P, Eichwald V, et al. CD44 expressed by myeloid cells promotes glioma invasion. Front Oncol. 2022;12:969787.","journal-title":"Front Oncol"},{"key":"3767_CR153","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1158\/1078-0432.CCR-08-2042","volume":"15","author":"JS Guillamo","year":"2009","unstructured":"Guillamo JS, de Bo\u00fcard S, Valable S, Marteau L, Leuraud P, Marie Y, et al. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma. Clin Cancer Res. 2009;15:3697\u2013704.","journal-title":"Clin Cancer Res"},{"key":"3767_CR154","doi-asserted-by":"publisher","first-page":"18002","DOI":"10.1038\/s41598-018-36280-9","volume":"8","author":"JJ Parker","year":"2018","unstructured":"Parker JJ, Canoll P, Niswander L, Kleinschmidt-DeMasters BK, Foshay K, Waziri A. Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma. Sci Rep. 2018;8:18002.","journal-title":"Sci Rep"},{"key":"3767_CR155","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.celrep.2017.06.036","volume":"20","author":"N Pencheva","year":"2017","unstructured":"Pencheva N, de Gooijer MC, Vis DJ, Wessels LFA, W\u00fcrdinger T, van Tellingen O, et al. Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness. Cell Rep. 2017;20:48\u201360.","journal-title":"Cell Rep"},{"key":"3767_CR156","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/neuonc\/not003","volume":"15","author":"F Merz","year":"2013","unstructured":"Merz F, Gaunitz F, Dehghani F, Renner C, Meixensberger J, Gutenberg A, et al. Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments. Neuro Oncol. 2013;15:670\u201381.","journal-title":"Neuro Oncol"},{"key":"3767_CR157","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev.pathol.3.121806.154244","volume":"6","author":"DJ Cheon","year":"2011","unstructured":"Cheon DJ, Orsulic S. Mouse models of cancer. Annu Rev Pathol. 2011;6:95\u2013119.","journal-title":"Annu Rev Pathol"},{"key":"3767_CR158","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/neuonc\/noae131","volume":"26","author":"J Figg","year":"2024","unstructured":"Figg J, Chen D, Falceto Font L, Flores C, Jin D. vivo mouse models for adult brain tumors: Exploring tumorigenesis and advancing immunotherapy development. Neuro Oncol. 2024;26:1964\u201380.","journal-title":"Neuro Oncol"},{"key":"3767_CR159","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, et al. NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100:3175\u201382.","journal-title":"Blood"},{"key":"3767_CR160","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.celrep.2012.12.013","volume":"3","author":"KM Joo","year":"2013","unstructured":"Joo KM, Kim J, Jin J, Kim M, Seol HJ, Muradov J, et al. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep. 2013;3:260\u201373.","journal-title":"Cell Rep"},{"key":"3767_CR161","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/glia.21142","volume":"59","author":"D Hambardzumyan","year":"2011","unstructured":"Hambardzumyan D, Parada LF, Holland EC, Charest A. Genetic modeling of gliomas in mice: new tools to tackle old problems. Glia. 2011;59:1155\u201368.","journal-title":"Glia"},{"key":"3767_CR162","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cam4.219","volume":"3","author":"A Torsvik","year":"2014","unstructured":"Torsvik A, Stieber D, Enger P\u00d8, Golebiewska A, Molven A, Svendsen A, et al. U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med. 2014;3:812\u201324.","journal-title":"Cancer Med"},{"key":"3767_CR163","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","volume":"9","author":"J Lee","year":"2006","unstructured":"Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006;9:391\u2013403.","journal-title":"Cancer Cell"},{"key":"3767_CR164","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-19-0909","volume":"26","author":"RA Vaubel","year":"2020","unstructured":"Vaubel RA, Tian S, Remonde D, Schroeder MA, Mladek AC, Kitange GJ, et al. Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma. Clin Cancer Res. 2020;26:1094\u20134.","journal-title":"Clin Cancer Res"},{"key":"3767_CR165","first-page":"vdab100","volume":"3","author":"AF Haddad","year":"2021","unstructured":"Haddad AF, Young JS, Amara D, Berger MS, Raleigh DR, Aghi MK, et al. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neurooncol Adv. 2021;3:vdab100.","journal-title":"Neurooncol Adv"},{"key":"3767_CR166","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98\u2013110.","journal-title":"Cancer Cell"},{"key":"3767_CR167","first-page":"820","volume":"19","author":"J Teng","year":"2017","unstructured":"Teng J, da Hora CC, Kantar RS, Nakano I, Wakimoto H, Batchelor TT, et al. Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models. Neuro Oncol. 2017;19:820\u201332.","journal-title":"Neuro Oncol"},{"key":"3767_CR168","doi-asserted-by":"publisher","first-page":"1129627","DOI":"10.3389\/fonc.2023.1129627","volume":"13","author":"J Alcaniz","year":"2023","unstructured":"Alcaniz J, Winkler L, Dahlmann M, Becker M, Orthmann A, Haybaeck J, et al. Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures. Front Oncol. 2023;13:1129627.","journal-title":"Front Oncol"},{"key":"3767_CR169","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/path.1711030410","volume":"103","author":"H Fraser","year":"1971","unstructured":"Fraser H. Astrocytomas in an inbred mouse strain. J Pathol. 1971;103:266\u201370.","journal-title":"J Pathol"},{"key":"3767_CR170","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00688850","volume":"51","author":"RD Serano","year":"1980","unstructured":"Serano RD, Pegram CN, Bigner DD. Tumorigenic cell culture lines from a spontaneous VM\/Dk murine astrocytoma (SMA). Acta Neuropathol. 1980;51:53\u201364.","journal-title":"Acta Neuropathol"},{"key":"3767_CR171","first-page":"2394","volume":"30","author":"JI Ausman","year":"1970","unstructured":"Ausman JI, Shapiro WR, Rall DP. Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res. 1970;30:2394\u2013400.","journal-title":"Cancer Res"},{"key":"3767_CR172","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41419-018-1062-3","volume":"9","author":"X Guan","year":"2018","unstructured":"Guan X, Hasan MN, Begum G, Kohanbash G, Carney KE, Pigott VM, et al. Blockade of Na\/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy. Cell Death Dis. 2018;9:1010.","journal-title":"Cell Death Dis"},{"key":"3767_CR173","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers13010019","volume":"13","author":"R Wouters","year":"2020","unstructured":"Wouters R, Bevers S, Riva M, De Smet F, Coosemans A. Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma. Cancers (Basel). 2020;13:19.","journal-title":"Cancers (Basel)"},{"key":"3767_CR174","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/2152-7806.123656","volume":"4","author":"AJ Ghods","year":"2013","unstructured":"Ghods AJ, Glick R, Braun D, Feinstein D. Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas. Surg Neurol Int. 2013;4:160.","journal-title":"Surg Neurol Int"},{"key":"3767_CR175","first-page":"vdab066","volume":"3","author":"ZP Tritz","year":"2021","unstructured":"Tritz ZP, Ayasoufi K, Johnson AJ. Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail. Neurooncol Adv. 2021;3:vdab066.","journal-title":"Neurooncol Adv"},{"key":"3767_CR176","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1038\/s41467-020-17704-5","volume":"11","author":"JK Khalsa","year":"2020","unstructured":"Khalsa JK, Cheng N, Keegan J, Chaudry A, Driver J, Bi WL, et al. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types. Nat Commun. 2020;11:3912.","journal-title":"Nat Commun"},{"key":"3767_CR177","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11060-021-03822-7","volume":"154","author":"B Noffsinger","year":"2021","unstructured":"Noffsinger B, Witter A, Sheybani N, Xiao A, Manigat L, Zhong Q, et al. Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner. J Neurooncol. 2021;154:145\u201357.","journal-title":"J Neurooncol"},{"key":"3767_CR178","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1158\/2326-6066.CIR-16-0156","volume":"4","author":"TM Johanns","year":"2016","unstructured":"Johanns TM, Ward JP, Miller CA, Wilson C, Kobayashi DK, Bender D, et al. Endogenous neoantigen-specific CD8 T cells identified in two glioblastoma models using a cancer immunogenomics approach. Cancer Immunol Res. 2016;4:1007\u201315.","journal-title":"Cancer Immunol Res"},{"key":"3767_CR179","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2326-6066.CIR-15-0151","volume":"4","author":"DA Reardon","year":"2016","unstructured":"Reardon DA, Gokhale PC, Klein SR, Ligon KL, Rodig SJ, Ramkissoon SH, et al. Glioblastoma eradication following immune checkpoint blockade in an orthotopic, immunocompetent model. Cancer Immunol Res. 2016;4:124\u201335.","journal-title":"Cancer Immunol Res"},{"key":"3767_CR180","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","volume":"20","author":"DA Wainwright","year":"2014","unstructured":"Wainwright DA, Chang AL, Dey M, Balyasnikova IV, Kim CK, Tobias A, et al. Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors. Clin Cancer Res. 2014;20:5290\u2013301.","journal-title":"Clin Cancer Res"},{"key":"3767_CR181","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ccell.2017.07.006","volume":"32","author":"D Saha","year":"2017","unstructured":"Saha D, Martuza RL, Rabkin SD. Macrophage polarization contributes to glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade. Cancer Cell. 2017;32:253\u2013e675.","journal-title":"Cancer Cell"},{"key":"3767_CR182","first-page":"1309","volume":"22","author":"R Mart\u00ednez-Murillo","year":"2007","unstructured":"Mart\u00ednez-Murillo R, Mart\u00ednez A. Standardization of an orthotopic mouse brain tumor model following transplantation of CT-2A astrocytoma cells. Histol Histopathol. 2007;22:1309\u201326.","journal-title":"Histol Histopathol"},{"key":"3767_CR183","doi-asserted-by":"publisher","first-page":"166","DOI":"10.7150\/jca.4149","volume":"3","author":"E Binello","year":"2012","unstructured":"Binello E, Qadeer ZA, Kothari HP, Emdad L, Germano IM. Stemness of the CT-2A immunocompetent mouse brain tumor model: characterization in vitro. J Cancer. 2012;3:166\u201374.","journal-title":"J Cancer"},{"key":"3767_CR184","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1158\/1078-0432.CCR-08-0213","volume":"14","author":"J Marsh","year":"2008","unstructured":"Marsh J, Mukherjee P, Seyfried TN. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue\/tuberous sclerosis complex 2-deficient mouse astrocytoma. Clin Cancer Res. 2008;14:7751\u201362.","journal-title":"Clin Cancer Res"},{"key":"3767_CR185","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13014-022-01990-y","volume":"17","author":"KJ McKelvey","year":"2022","unstructured":"McKelvey KJ, Hudson AL, Donaghy H, Stoner SP, Wheeler HR, Diakos CI, et al. Differential effects of radiation fractionation regimens on glioblastoma. Radiat Oncol. 2022;17:17.","journal-title":"Radiat Oncol"},{"key":"3767_CR186","doi-asserted-by":"publisher","first-page":"115296","DOI":"10.1016\/j.biopha.2023.115296","volume":"166","author":"R Maeoka","year":"2023","unstructured":"Maeoka R, Ouji Y, Nakazawa T, Matsuda R, Morimoto T, Yokoyama S, et al. Local administration of shikonin improved the overall survival in orthotopic murine glioblastoma models with temozolomide resistance. Biomed Pharmacother. 2023;166:115296.","journal-title":"Biomed Pharmacother"},{"key":"3767_CR187","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41598-017-18540-2","volume":"8","author":"H Nakashima","year":"2018","unstructured":"Nakashima H, Alayo QA, Penaloza-MacMaster P, Freeman GJ, Kuchroo VK, Reardon DA, et al. Modeling tumor immunity of mouse glioblastoma by exhausted CD8\u2009+\u2009T cells. Sci Rep. 2018;8:208.","journal-title":"Sci Rep"},{"key":"3767_CR188","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/neuonc\/noaa050","volume":"22","author":"CJ Liu","year":"2020","unstructured":"Liu CJ, Schaettler M, Blaha DT, Bowman-Kirigin JA, Kobayashi DK, Livingstone AJ, et al. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine. Neuro Oncol. 2020;22:1276\u201388.","journal-title":"Neuro Oncol"},{"key":"3767_CR189","doi-asserted-by":"publisher","first-page":"1297932","DOI":"10.3389\/fimmu.2023.1297932","volume":"14","author":"JB Iorgulescu","year":"2023","unstructured":"Iorgulescu JB, Ruthen N, Ahn R, Panagioti E, Gokhale PC, Neagu M, et al. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Front Immunol. 2023;14:1297932.","journal-title":"Front Immunol"},{"key":"3767_CR190","doi-asserted-by":"publisher","first-page":"1092399","DOI":"10.3389\/fimmu.2022.1092399","volume":"13","author":"SC Frederico","year":"2023","unstructured":"Frederico SC, Zhang X, Hu B, Kohanbash G. Pre-clinical models for evaluating glioma targeted immunotherapies. Front Immunol. 2023;13:1092399.","journal-title":"Front Immunol"},{"key":"3767_CR191","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1038\/s41467-026-69606-7","volume":"17","author":"YD Li","year":"2026","unstructured":"Li YD, Giles DA, Huang Y, Kesarwani A, Hu T, Page L, et al. Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma. Nat Commun. 2026;17:2893.","journal-title":"Nat Commun"},{"key":"3767_CR192","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13046-023-02686-1","volume":"42","author":"F Liu","year":"2023","unstructured":"Liu F, Zhou Q, Jiang HF, Zhang TT, Miao C, Xu XH, et al. Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity. J Exp Clin Cancer Res. 2023;42:118.","journal-title":"J Exp Clin Cancer Res"},{"key":"3767_CR193","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1097\/00006123-199712000-00024","volume":"41","author":"JH Sampson","year":"1997","unstructured":"Sampson JH, Ashley DM, Archer GE, Fuchs HE, Dranoff G, Hale LP, et al. Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion. Neurosurgery. 1997;41:1365\u201372. discussion 1372-3.","journal-title":"Neurosurgery"},{"key":"3767_CR194","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1215\/15228517-2007-010","volume":"9","author":"TT Tran","year":"2007","unstructured":"Tran TT, Uhl M, Ma JY, Janssen L, Sriram V, Aulwurm S, et al. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model. Neuro Oncol. 2007;9:259\u201370.","journal-title":"Neuro Oncol"},{"key":"3767_CR195","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.2147\/IJN.S419712","volume":"18","author":"C He","year":"2023","unstructured":"He C, Ding H, Li L, Chen J, Mo X, Ding Y, et al. Gold nanoparticles enhance the ability of radiotherapy to induce immunogenic cell death in glioblastoma. Int J Nanomed. 2023;18:5701\u201312.","journal-title":"Int J Nanomed"},{"key":"3767_CR196","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/bloodadvances.2018015966","volume":"3","author":"B Costa","year":"2019","unstructured":"Costa B, Eisemann T, Strelau J, Spaan I, Korshunov A, Liu HK, et al. Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells. Blood Adv. 2019;3:1092\u2013102.","journal-title":"Blood Adv"},{"key":"3767_CR197","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1750-3639.2008.00234.x","volume":"19","author":"JT Huse","year":"2009","unstructured":"Huse JT, Holland EC. Genetically engineered mouse models of brain cancer and the promise of preclinical testing. Brain Pathol. 2009;19:132\u201343.","journal-title":"Brain Pathol"},{"key":"3767_CR198","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","volume":"187","author":"R Mathur","year":"2024","unstructured":"Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, et al. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024;187:446\u2013e6316.","journal-title":"Cell"},{"key":"3767_CR199","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1158\/1078-0432.CCR-06-3058","volume":"13","author":"P McConville","year":"2007","unstructured":"McConville P, Hambardzumyan D, Moody JB, Leopold WR, Kreger AR, Woolliscroft MJ, et al. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. Clin Cancer Res. 2007;13:2897\u2013904.","journal-title":"Clin Cancer Res"},{"key":"3767_CR200","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1158\/1535-7163.MCT-10-0248","volume":"9","author":"H Zhu","year":"2010","unstructured":"Zhu H, Woolfenden S, Bronson RT, Jaffer ZM, Barluenga S, Winssinger N, et al. The novel Hsp90 inhibitor NXD30001 induces tumor regression in a genetically engineered mouse model of glioblastoma multiforme. Mol Cancer Ther. 2010;9:2618\u201326.","journal-title":"Mol Cancer Ther"},{"key":"3767_CR201","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/1078-0432.CCR-16-1276","volume":"23","author":"F Lin","year":"2017","unstructured":"Lin F, de Gooijer MC, Hanekamp D, Chandrasekaran G, Buil LC, Thota N, et al. PI3K-mTOR pathway inhibition exhibits efficacy against high-grade glioma in clinically relevant mouse models. Clin Cancer Res. 2017;23:1286\u201398.","journal-title":"Clin Cancer Res"},{"key":"3767_CR202","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40478-025-01991-4","volume":"13","author":"M Seblani","year":"2025","unstructured":"Seblani M, Zannikou M, Duffy J, Levine R, Thakur A, Puigdelloses-Vallcorba M, et al. IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas. Acta Neuropathol Commun. 2025;13:69.","journal-title":"Acta Neuropathol Commun"},{"key":"3767_CR203","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/nn.4620","volume":"20","author":"RD Chow","year":"2017","unstructured":"Chow RD, Guzman CD, Wang G, Schmidt F, Youngblood MW, Ye L, et al. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma. Nat Neurosci. 2017;20:1329\u201341.","journal-title":"Nat Neurosci"},{"key":"3767_CR204","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/neuonc\/nox129","volume":"20","author":"GJ Rahme","year":"2018","unstructured":"Rahme GJ, Luikart BW, Cheng C, Israel MA. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma. Neuro Oncol. 2018;20:332\u201342.","journal-title":"Neuro Oncol"},{"key":"3767_CR205","doi-asserted-by":"publisher","first-page":"11241","DOI":"10.1073\/pnas.91.23.11241","volume":"91","author":"MJ Federspiel","year":"1994","unstructured":"Federspiel MJ, Bates P, Young JA, Varmus HE, Hughes SH. A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proc Natl Acad Sci U S A. 1994;91:11241\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3767_CR206","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41467-018-03731-w","volume":"9","author":"B Oldrini","year":"2018","unstructured":"Oldrini B, Curiel-Garc\u00eda \u00c1, Marques C, Matia V, Ulu\u00e7kan \u00d6, Gra\u00f1a-Castro O, et al. Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling. Nat Commun. 2018;9:1466.","journal-title":"Nat Commun"},{"key":"3767_CR207","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/0008-5472.CAN-08-1800","volume":"69","author":"SM Wiesner","year":"2009","unstructured":"Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, et al. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res. 2009;69:431\u20139.","journal-title":"Cancer Res"},{"key":"3767_CR208","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcdb.2014.01.006","volume":"27","author":"BR Tschida","year":"2014","unstructured":"Tschida BR, Largaespada DA, Keng VW. Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies. Semin Cell Dev Biol. 2014;27:86\u201395.","journal-title":"Semin Cell Dev Biol"},{"key":"3767_CR209","first-page":"52443","volume":"96","author":"AA Calinescu","year":"2015","unstructured":"Calinescu AA, N\u00fa\u00f1ez FJ, Koschmann C, Kolb BL, Lowenstein PR, Castro MG. Transposon mediated integration of plasmid DNA into the subventricular zone of neonatal mice to generate novel models of glioblastoma. J Vis Exp. 2015;96:52443.","journal-title":"J Vis Exp"},{"key":"3767_CR210","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0092-8674(00)81826-7","volume":"87","author":"JZ Tsien","year":"1996","unstructured":"Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, et al. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 1996;87:1317\u201326.","journal-title":"Cell"},{"key":"3767_CR211","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/0008-5472.CAN-22-1577","volume":"83","author":"R Verma","year":"2023","unstructured":"Verma R, Chen X, Xin D, Luo Z, Ogurek S, Xin M, et al. Olig1\/2-Expressing intermediate lineage progenitors are predisposed to PTEN\/p53-loss-induced gliomagenesis and harbor specific therapeutic vulnerabilities. Cancer Res. 2023;83:890\u2013905.","journal-title":"Cancer Res"},{"key":"3767_CR212","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014;159:440\u201355.","journal-title":"Cell"},{"key":"3767_CR213","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34:184\u201391.","journal-title":"Nat Biotechnol"},{"key":"3767_CR214","doi-asserted-by":"publisher","first-page":"101139","DOI":"10.1016\/j.neo.2025.101139","volume":"62","author":"SR Wu","year":"2025","unstructured":"Wu SR, Sharpe J, Tolliver J, Groth AJ, Chen R, Guerra Garc\u00eda ME, et al. Combining the RCAS\/tv-a retrovirus and CRISPR\/Cas9 gene editing systems to generate primary mouse models of diffuse midline glioma. Neoplasia. 2025;62:101139.","journal-title":"Neoplasia"},{"key":"3767_CR215","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","volume":"40","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, Will P, Kueckelhaus J, Sun N, Joseph K, Sali\u00e9 H, et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell. 2022;40:639\u2013e5513.","journal-title":"Cancer Cell"},{"key":"3767_CR216","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41467-023-36707-6","volume":"14","author":"Y Ren","year":"2023","unstructured":"Ren Y, Huang Z, Zhou L, Xiao P, Song J, He P, et al. Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. Nat Commun. 2023;14:1028.","journal-title":"Nat Commun"},{"key":"3767_CR217","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s11517-020-02179-9","volume":"58","author":"N Wijethilake","year":"2020","unstructured":"Wijethilake N, Islam M, Ren H. Radiogenomics model for overall survival prediction of glioblastoma. Med Biol Eng Comput. 2020;58:1767\u201377.","journal-title":"Med Biol Eng Comput"},{"key":"3767_CR218","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-025-01692-3","author":"S Buzdugan","year":"2025","unstructured":"Buzdugan S, Mazher M, Puig D. Radiogenomics for Glioblastoma Survival Prediction: Integrating Radiomics, Clinical, and Genomic Features Using Artificial Intelligence. J Imaging Inf Med. 2025. https:\/\/doi.org\/10.1007\/s10278-025-01692-3.","journal-title":"J Imaging Inf Med"},{"key":"3767_CR219","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.3390\/ijms26199362","volume":"26","author":"G Morello","year":"2025","unstructured":"Morello G, La Cognata V, Guarnaccia M, Gentile G, Cavallaro S. Artificial Intelligence-Driven Multi-Omics Approaches in Glioblastoma. Int J Mol Sci. 2025;26:9362.","journal-title":"Int J Mol Sci"},{"key":"3767_CR220","doi-asserted-by":"publisher","first-page":"152429","DOI":"10.1016\/j.seminoncol.2025.152429","volume":"52","author":"M Pourmadadi","year":"2025","unstructured":"Pourmadadi M, Shabestari SM, Abdouss H, Rahdar A, Fathi-Karkan S, Pandey S. Artificial intelligence-driven intelligent nanocarriers for cancer theranostics: A paradigm shift with focus on brain tumors. Semin Oncol. 2025;52:152429.","journal-title":"Semin Oncol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03767-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:45:22Z","timestamp":1789443922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03767-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":220,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3767"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03767-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"196"}}